[E16-03 ] Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy
Last updated 24.06.2024
Project no.:
E16-03
Commission:
Commission awarded on 13.04.2016 by the Federal Joint Committee (G-BA).
Report type:
Assessment of potential
Status:
Commission completed
Department/Division:
Non-Drug Interventions
Application field:
Head and nerves
Note:
Within the framework of the testing regulation (German version) the Federal Joint Committee (G-BA) can commission IQWiG to assess the potential of a new examination or treatment method (i.e. of a medical device). As part of an administrative procedure conducted by the G-BA, the topics and content of the assessments of the potential of medical devices are confidential until the testing directive is passed (German version).
DOI:
https://doi.org/10.60584/E16-03
| Project no. | Title | Status |
|---|---|---|
| E16-04 | Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy - Addendum to Commission E16-03 | Commission completed |
| E23-07 | Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy –Third addendum to Commission E16-03 | Commission completed |
| E20-06 | Transcutaneous vagus nerve stimulation in pharmacoresistant epilepsy – Second addendum to Commission E16-03 | Commission completed |